Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
6
×
detroit top stories
eli lilly
6
×
indiana blog main
indiana top stories
life sciences
medicare
6
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
6
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
clinical trials
startups
cancer immunotherapy
deals
fda
alzheimer's disease
biogen
bristol-myers squibb
drug prices
gene therapy
What
bio
6
×
roundup
alzheimer’s
companies
drug
pharmaceutical
price
prices
week
annual
appetite
approval
arena’s
assessed
attention
biogen’s
biopharmaceutical
biotech
black
bounty
bread
butter
buyout
cancer
cash
cig
comeback
communities
conference
congress
convo
corner
deals
delivered
democrats
diabetes
diamond’s
different
divided
drugs
Language
Current search:
medicare
×
bio
×
" detroit blog main "
×
" san diego blog main "
×
" eli lilly "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More